Regenerative Tissue Engineering and Transplantation
joint with Mechanisms of Whole Organ Regeneration
Organizer(s): Rocky S. Tuan, Farshid Guilak and Anthony AtalaDate: April 01 - 06, 2012
Location: Beaver Run Resort, Breckenridge, CO, USA
Tissue engineering and regenerative medicine is a dynamic, translational research field that amalgamates life sciences, engineering and clinical medicine for the purpose of restoring structure and function to diseased, damaged or injured tissues and organs. Current efforts focus on the application of stem and progenitor cells, bioactive factors and biomaterial scaffolds in transplantation procedures to affect regenerative therapies. Breakthroughs in bladder and tracheal reconstruction and highly promising approaches for solid organ regeneration as well as musculoskeletal and nerve repair have been achieved. Effective cell sourcing, optimal assembly and fabrication of tissue-derived and synthetic biomaterial scaffolds, and targeted regulation of therapeutic and immunomodulatory functions of stem cells represent some of the current challenges in this field. In this Keystone Symposia meeting on Regenerative Tissue Engineering and Transplantation, exciting technological and intellectual advances in the field will be synthesized by expert scientists, engineers and clinicians to assess and expand the landscape in regenerative engineering and transplantation. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Mechanisms of Whole Organ Regeneration, which will share an opening and closing keynote address as well as two plenary sessions with this meeting. More specifically, the pairing of these two meetings represents a highly unusual opportunity for cross-talk between the more applications-driven field of tissue engineering and regenerative medicine, and the very basic research being explored in the field of whole organ regeneration.
Scholarship Deadline: December 2 2011
Discounted Abstract Deadline: December 1 2011
Abstract Deadline: January 6 2012
Discounted Registration Deadline: February 1 2012
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Osiris Therapeutics, Inc.
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Grant No. 1R13EB014683-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.